According to Aerovate Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.60. In 2022 the company made an earnings per share (EPS) of -$2.11 an increase over its 2021 EPS that were of -$24.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.60 | 23.22% |
2022 | -$2.11 | -91.4% |
2021 | -$24.53 | -29.07% |
2020 | -$34.58 |